ArticleCancer medicine2015

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.

Uma Raju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.